246960 — InnoTherapy Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
KR₩61bn
Enterprise Value
KR₩60bn
Revenue
KR₩1bn

Annual balance sheet for InnoTherapy, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,752	4,638	10,421	4,821	9,045
Net Total Accounts Receivable
Net Total Receivables	241	525	239	204	1,073
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,423	5,519	10,858	5,469	10,546
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,101	4,680	10,460	13,882	15,774
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	17,233	17,351	31,883	30,814	30,158
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	950	836	657	2,465	3,356
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,150	4,408	21,804	17,769	11,255
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	15,082	12,943	10,079	13,045	18,903
Total Liabilities & Shareholders' Equity	17,233	17,351	31,883	30,814	30,158
Total Common Shares Outstanding
Total Preferred Shares Outstanding